
CapsoVision Inc (CV) Earnings Dates & Reports
CapsoVision Inc (CV) Most Recent Earnings
Report Date
Period EndingQ4 2025
Est. EPS-$0.15
Actual EPS$0.02
EarningsBeat
CapsoVision Inc (CV) Earnings
View the latest CapsoVision Inc (CV) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in CapsoVision Inc (CV)
Order type
Buy in
Order amount
Est. shares
0 shares
CapsoVision Inc (CV) Earnings per Share (EPS) History
Signup for full accessBrowse free
CapsoVision Inc (CV) Latest Earnings
The value each CV share was expected to gain vs. the value each share gained.
CapsoVision Inc (CV) reported its most recent earnings on for Q4 2025, posting earnings per share (EPS) of $0.02. This exceeded analysts' expectations of -$0.15 by 113.33%, marking a Beat.
For comparison, CapsoVision Inc reported EPS of $0 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.13.
CapsoVision Inc (CV) Earnings History
CapsoVision Inc (CV) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the CapsoVision Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — |
CapsoVision Inc (CV) Earnings FAQs
CapsoVision Inc (CV) last reported earnings on Mar 26, 2026 for Q4 2025, posting an EPS of $0.02, which Beat the estimate of -$0.15 by 113.33%.
For Q4 2025, CapsoVision Inc (CV) reported an EPS of $0.02, exceeding analysts' estimate of -$0.15 by 113.33%.
For Q4 2025, CapsoVision Inc (CV) Beat expectations with an actual EPS of $0.02 vs. an estimated EPS of -$0.15.
Following the last earnings report on Mar 26, 2026, CapsoVision Inc (CV)'s stock price moved — from — to —.
The next CapsoVision Inc (CV) earnings call is scheduled for May. 20, 2026, where executives will discuss financial results and outlook.